← Back to Search

Behavioral Intervention

Brief Intervention for Opioid Use Disorder with Alcohol Consumption (COAPS Trial)

N/A

Recruiting

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months. changes in alcohol use will be assessed by comparing baseline to month 2. changes in alcohol use will also be assessed by comparing month 2 to month 3.

Awards & highlights

COAPS Trial Summary

This trial aims to develop an intervention to reduce co-use of opioids & alcohol & test its effectiveness. Results will inform a larger trial.

Who is the study for?

This trial is for English-speaking adults over 18 who currently use alcohol and are prescribed opioids, but not for cancer treatment. They must have a reliable phone and stay in the area for the next 3 months. It's not for those using only buprenorphine, pregnant individuals, anyone planning to leave the area soon, or those with recent psychotic/manic episodes.Check my eligibility

What is being tested?

The study is testing an intervention adapted from one designed to address opioid misuse. Participants will receive either Alcohol-targeted Brief Intervention-Medication Therapy Management or standard medication counseling to prevent co-use of opioids and alcohol.See study design

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medications, traditional side effects like you'd see with drugs aren't expected. However, participants may experience discomfort discussing personal substance use habits.

COAPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months. changes in alcohol use will be assessed by comparing baseline to month 2. changes in alcohol use will also be assessed by comparing month 2 to month 3.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months. changes in alcohol use will be assessed by comparing baseline to month 2. changes in alcohol use will also be assessed by comparing month 2 to month 3.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months. changes in alcohol use will be assessed by comparing baseline to month 2. changes in alcohol use will also be assessed by comparing month 2 to month 3. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Alcohol use reductions

Non opioid medication alternative

COAPS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Alcohol-targeted Brief Intervention-Medication Therapy ManagementExperimental Treatment1 Intervention

Alcohol-targeted Brief Intervention-Medication Therapy Management (ABI-MTM) intervention is a pharmacy-based medication management intervention, combined with Screening, Brief Intervention, and Referral to Treatment

Group II: Standard medication counselingActive Control1 Intervention

Standard Medication Counseling (SMC) (1) will offer counseling, (2) document counseling was offered, (3) offer a counseling process for patients not present, and (4) discuss generic substitution. Following this session, in the second SMC component, participants will be emailed/mailed (according to participant preference) safety information about co-use of alcohol and opioids

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,100 Previous Clinical Trials

1,778,861 Total Patients Enrolled

Media Library

Alcohol-targeted Brief Intervention-Medication Therapy Management (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05599672 — N/A

Alcohol Consumption Research Study Groups: Alcohol-targeted Brief Intervention-Medication Therapy Management, Standard medication counseling

Alcohol Consumption Clinical Trial 2023: Alcohol-targeted Brief Intervention-Medication Therapy Management Highlights & Side Effects. Trial Name: NCT05599672 — N/A

Alcohol-targeted Brief Intervention-Medication Therapy Management (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05599672 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining for participants within this research project?

"Yes, according to clinicaltrials.gov the trial is still open for enrollment. It was initially published on May 10th 2023 and its parameters were last modified on May 26th of that same year. This study seeks 40 participants from a single site."

Answered by AI

What is the capacity of this research endeavor?

"Affirmative. The clinicaltrials.gov website implies that recruitment is ongoing for this medical trial, which was inaugurated on May 10th 2023 and most recently updated on May 26th. Currently 40 individuals need to be enrolled from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Co-Use of Opioid Medications and Alcohol Prevention Study

2023. "Co-Use of Opioid Medications and Alcohol Prevention Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05599672.